Mr. Aaron Matthew Thomas, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1653 Mooresville Hwy, Lewisburg, TN 37091 Phone: 931-359-4506 Fax: 931-359-8139 |
Brittany Miller, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1653 Mooresville Hwy, Lewisburg, TN 37091 Phone: 931-246-1317 |
Kristen M Hall, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1653 Mooresville Hwy, Lewisburg, TN 37091 Phone: 931-246-1315 |
Dominic Montalto, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 712 N Ellington Pkwy Ste 6, Lewisburg, TN 37091 Phone: 931-359-1913 |
Therese Hooks, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1653 Mooresville Hwy, Lewisburg, TN 37091 Phone: 931-359-4506 |
Mrs. Rita Marie Hayek Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 244 Oakwood Dr, Lewisburg, TN 37091 Phone: 931-359-3563 |
Mrs. Shirley Holmes, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1653 Mooresville Hwy, Lewisburg, TN 37091 Phone: 931-359-4506 |
News Archive
A new study published in the journal Nature Medicine on December 23, 2019, shows how to silence a defective gene responsible for the degeneration of the motor neurons in Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS), in adult mice. This could help prevent disease progression if the condition is already symptomatic, and even suppress the illness if it has not yet started.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established yet another agreement with a large biotechnology company for the evaluation of a novel oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
The number of people living with dementia is expected to double to 65.7 million by 2030 and more than triple by 2050, with "the current estimated cost of treating and caring for those with the condition at $604 billion a year," according to a report released Wednesday by the WHO and Alzheimer's Disease International, Agence France-Presse reports.
Health Affairs July 2013 issue describes health success stories outside USOne, by Sema Sgaier of the Bill & Melinda Gates Foundation, and colleagues, is titled "How The Avahan HIV Prevention Program Transitioned From The Gates Foundation To The Government Of India."
Researchers have developed "custom" nanoparticles that promise to provide a more targeted and effective way of delivering anticancer drugs than conventional medications or any of the earlier attempts to fight cancer with nanoparticles.
› Verified 8 days ago